GlobeNewsWire · TIL · October 28, 2026
Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: GlobeNewsWire ↗